NCT07403630 2026-02-17IT-TCP POSAzienda Ospedaliero-Universitaria di ParmaPhase NA Recruiting300 enrolled
NCT06362369 2025-09-17A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled